Literature DB >> 11222370

Assessment of mechanism of acquired skewed X inactivation by analysis of twins.

M A Vickers1, E McLeod, T D Spector, I J Wilson.   

Abstract

Skewed X-chromosome inactivation in peripheral blood granulocytes becomes more frequent with increasing age, affecting up to half of those over 75 years old. To investigate the mechanisms underlying this phenomenon, X-inactivation profiles in 33 monozygotic and 22 dizygotic elderly twin pairs were studied. Differential methylation-sensitive restriction enzyme cutting at a hypervariable locus in the human androgen receptor gene (HUMARA) was studied on purified granulocytes using T cells as controls. A large genetic effect on skewed granulocytic X inactivation was shown (P <.05); heritability was estimated to be 0.68. A minor part (SD.0151 relative allele frequency [ie, larger/smaller] units) of the observed variance is due to experimental error. A further contributor to acquired skewing is stochastic asymmetric stem cell division, which was modeled and shown as unlikely to account for a substantial part of variance. Two monozygotic twin pairs had X-inactivation ratios skewed markedly in opposite directions, evidence for a further stochastic mechanism, suggestive of a single overrepresented clone. In conclusion, all 3 suggested mechanisms contribute to acquired X inactivation but the dominant mechanism is genetic selection. The observed proportion of putatively clonal hematopoiesis is similar to the lifetime incidence of hematopoietic stem cell malignancy consistent with the concept that clonal hematopoiesis precedes stem cell malignancy.

Entities:  

Mesh:

Year:  2001        PMID: 11222370     DOI: 10.1182/blood.v97.5.1274

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  X-linked clonality testing: interpretation and limitations.

Authors:  George L Chen; Josef T Prchal
Journal:  Blood       Date:  2007-04-13       Impact factor: 22.113

2.  No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans.

Authors:  Véronique Bolduc; Pierre Chagnon; Sylvie Provost; Marie-Pierre Dubé; Claude Belisle; Marianne Gingras; Luigina Mollica; Lambert Busque
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 3.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

4.  Natural gene therapy in monozygotic twins with Fanconi anemia.

Authors:  Anuj Mankad; Toshiyasu Taniguchi; Barbara Cox; Yassmine Akkari; R Keaney Rathbun; Lora Lucas; Grover Bagby; Susan Olson; Alan D'Andrea; Markus Grompe
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

Review 5.  Concise Review: Age-Related Clonal Hematopoiesis: Stem Cells Tempting the Devil.

Authors:  Lambert Busque; Manuel Buscarlet; Luigina Mollica; Ross L Levine
Journal:  Stem Cells       Date:  2018-06-08       Impact factor: 6.277

6.  Skewed X chromosome inactivation and trisomic spontaneous abortion: no association.

Authors:  Dorothy Warburton; Jennie Kline; Ann Kinney; Chih-Yu Yu; Bruce Levin; Stephen Brown
Journal:  Am J Hum Genet       Date:  2009-07-30       Impact factor: 11.025

7.  Genetic Determinants of Epigenetic Patterns: Providing Insight into Disease.

Authors:  Emma Cazaly; Jac Charlesworth; Joanne L Dickinson; Adele F Holloway
Journal:  Mol Med       Date:  2015-03-26       Impact factor: 6.354

8.  Analysis of expansion of myeloid progenitors in mice to identify leukemic susceptibility genes.

Authors:  Vincent E Sollars; Ed Pequignot; Jay L Rothstein; Arthur M Buchberg
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

9.  The replication rate of human hematopoietic stem cells in vivo.

Authors:  Sandra N Catlin; Lambert Busque; Rosemary E Gale; Peter Guttorp; Janis L Abkowitz
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

Review 10.  Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.

Authors:  Emanuela Viggiano; Manuela Ergoli; Esther Picillo; Luisa Politano
Journal:  Hum Genet       Date:  2016-04-21       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.